US 10,213,392

Application 15/648,314 · Granted Feb 26, 2019

Pharmaceutical composition for use in medical and veterinary ophthalmology

Estimated expiration

June 10, 2029

2y 202d remaining

Confidence: high
High: no high-severity warning was raised, and any terminal disclaimer was resolved to the patents it references.
  • Could not fetch continuity data for application PCTRU2009000295: Resource not found (404)
Earliest effective filing
Jun 10, 2009
+ 20 years
Jun 10, 2029
PTA +0d
Jun 10, 2029
No TD
—
Final
Jun 10, 2029

This calculation includes patent term adjustment (PTA) under 35 U.S.C. §154(b). Patent term extension (PTE) under 35 U.S.C. §156 (for FDA-regulated products) is not included.

Calculation details

Base term

Filing date
July 12, 2017
Earliest effective filing
June 10, 2009
Issue date
February 26, 2019
PTA
0 days
Base expiry (before PTA)
June 10, 2029

June 10, 2009 + 20 years = June 10, 2029

  • Divisional of application 13/315,397, filed Dec 9, 2011, issued as US 9,724,313
  • Continuation-in-part of application PCTRU2009000295, filed Jun 10, 2009
  • Continuation-in-part of application PCTRU2009000295, filed Jun 10, 2009

Terminal disclaimers

No TD0 approved, 0 filed

Patent term extension under 35 U.S.C. §156, which can apply to certain drug, biologic, animal drug and medical device patents, is not included in this calculation. How PTE is calculated

You have the date. Your AI can have the file.

Application 15/648,314 · US 10,213,392

PatentReply compiles the prosecution history behind US 10,213,392: the claims as filed and as allowed, every Office Action and response, and the cited references, with each answer pointing back to the filed passage.

One new published application a month is free. The first compile takes a few minutes.

Strategy and filing changes require your approval.

How PatentReply handles an Office Action response →

Permanent link

www.patentreply.ai/tools/patent-expiration/US10213392

Data sourced from public USPTO records. This tool provides informational estimates and should not be relied upon as legal advice. Always verify patent expiration dates independently, especially where patent term extension, terminal disclaimers, or unusual continuity issues may apply.